Deborah T. Gold

Professor in Psychiatry and Behavioral Sciences

External Address: 
1507 Busse Bldg, Durham, NC 27710
Internal Office Address: 
Box 3003 Med Ctr, Durham, NC 27710
Phone: 
(919) 660-7530

Overview

My research has centered on the psychosocial consequences of chronic illness for older adults. Although I have studied breast cancer, syncope, head and neck cancer, Parkinson's disease and Paget's disease of bone, my primary interest and focus has been on osteoporosis and its psychological and social impact on those who suffer from it.

In particular, my current research focuses on compliance and persistence with osteoporosis medications. One current study focuses on the impact of race/ethnicity on medication decision making. We are trying to determine the relative weight of cost, convenience, dosing interval, efficacy, and safety in making medication decisions and taking medication on a regular basis as prescribed by a health care provider. I am also on the Steering Committees of two major observational studies with different osteoporosis medications.

Finally, I have worked with voluntary health organizations to translate our research findings into positive real-world outcomes for people with chronic illness. I serve on the Board of Trustees of the National Osteoporosis Foundation and am Chair of its Education Committee. I have also chaired the International Symposium on Osteoporosis (ISO) for the last 8 years.

Education & Training

  • Ph.D., Northwestern University

Behavioral and Physiology in Aging awarded by National Institutes of Health (Director). 2015 to 2020

Behavior And Physiology In Aging awarded by National Institutes of Health (Project Coordinator). 1999 to 2015

APOE, Quality of Life and Medical Costs in Late Life awarded by National Institutes of Health (Co Investigator). 2000 to 2004

Phase Ten Year Followup awarded by National Institutes of Health (Co Investigator). 1997 to 2000

Phse Ten-Year Follow Up awarded by National Institutes of Health (Co-Principal Investigator). 1995 to 1999

Phse Ten Year Follow-Up awarded by National Institutes of Health (Co-Principal Investigator). 1995 to 1999

Claude D Pepper Older Americans Independence Center awarded by National Institutes of Health (Co-Principal Investigator). 1992 to 1999

Alzheimer'S Disease Research Center awarded by National Institutes of Health (Co-Principal Investigator). 1985 to 1999

Osteoporosis And Disability In Life Care Community Women awarded by National Institutes of Health (Principal Investigator). 1992 to 1997

Claude D. Pepper Older Americans Independence Center awarded by National Institutes of Health (Co-Principal Investigator). 1993 to 1997

Pages

Gold, DT. "Compliance and Persistence with Osteoporosis Medications." Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition. July 19, 2013. 448-454. Full Text

Kerr, C, Bottomley, C, Shingler, S, Giangregorio, L, de Freitas, HM, Patel, C, Randall, S, and Gold, DT. "The importance of physical function to people with osteoporosis." Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 28.5 (May 2017): 1597-1607. Full Text

Diez-Perez, A, Naylor, KE, Abrahamsen, B, Agnusdei, D, Brandi, ML, Cooper, C, Dennison, E, Eriksen, EF, Gold, DT, Guañabens, N, Hadji, P, Hiligsmann, M, Horne, R, Josse, R, Kanis, JA, Obermayer-Pietsch, B, Prieto-Alhambra, D, Reginster, J-Y, Rizzoli, R, Silverman, S, Zillikens, MC, and Eastell, R. "International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates." Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 28.3 (March 2017): 767-774. Full Text

Eastell, R, O'Neill, TW, Hofbauer, LC, Langdahl, B, Reid, IR, Gold, DT, and Cummings, SR. "Postmenopausal osteoporosis." Nature reviews. Disease primers 2 (September 29, 2016): 16069-. (Review) Full Text

Modi, A, Gold, DT, Yang, X, Fan, C-PS, and Sajjan, SG. "Association Between Gastrointestinal Events and Health Care Resource Utilization Among Patients with Osteoporosis: Analysis of a U.S. Managed Care Population." Journal of managed care & specialty pharmacy 21.9 (September 2015): 811-821.

Silverman, SL, Siris, E, Kendler, DL, Belazi, D, Brown, JP, Gold, DT, Lewiecki, EM, Papaioannou, A, Simonelli, C, Ferreira, I, Balasubramanian, A, Dakin, P, Ho, P, Siddhanti, S, Stolshek, B, and Recknor, C. "Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study." Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 26.1 (January 2015): 361-372. Full Text

Gold, DT, Silverman, SL, Chastek, BJ, Cheng, L-I, Hunter, AG, White, JC, Van Voorhis, D, and Stolshek, BS. "A Patient Survey Study of Zoledronic Acid Utilization and Factors Associated with Persistence." ARTHRITIS & RHEUMATOLOGY 66 (October 2014): S509-S509.

Reynolds, K, Viswanathan, HN, Muntner, P, Harrison, TN, Cheetham, TC, Hsu, J-WY, Gold, DT, Silverman, S, Grauer, A, Morisky, DE, and O'Malley, CD. "Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates." Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 23.7 (September 2014): 2109-2120. Full Text

Nixon, A, Kerr, C, Doll, H, Naegeli, AN, Shingler, SL, Breheny, K, Burge, R, Gold, DT, and Silverman, S. "Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function." Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 25.6 (June 2014): 1775-1784. Full Text

Shen, W, Burge, R, Naegeli, AN, Shih, J, Alam, J, Gold, DT, and Silverman, S. "Psychometric properties of the osteoporosis assessment questionnaire (OPAQ) 2.0: results from the multiple outcomes of raloxifene evaluation (MORE) study." BMC musculoskeletal disorders 15 (January 2014): 374-. Full Text

Pages

Lunsford, J, Silverman, SL, and Gold, DT. "Reports of Depression in Older Women with Osteoporosis." March 2014.

Silverman, SL, Siris, E, Kendler, DL, Belazi, D, Brown, JP, Gold, DT, Lewiecki, EM, Papaioannou, A, Simonelli, C, Ferreira, I, Dakin, P, Siddhanti, S, Stolshek, B, and Recknor, C. "Persistence At 12 Months With Denosumab (Prolia (R)) In Postmenopausal Women With Osteoporosis: Interim Results From a Prospective Observational Study." October 2013.

Gold, DT, Calderon, A, and Silverman, SL. "THE IMPACT OF HEALTH BELIEFS ON OSTEOPOROSIS TREATMENT." April 2013.

Abelson, A, Thomas, TP, Gold, DT, Lange, JL, and Ringe, JD. "REAL-WORLD EFFECTIVENESS OF BISPHOSPHONATES FOR THE REDUCTION OF CLINICAL FRACTURES." April 2009.

Gold, DT, Bessette, L, Horne, R, Borenstein, J, Varon, SF, Wang, H, Satram-Hoang, S, Wagman, RB, Macarios, D, and Bone, HG. "PATIENT PREFERENCE AND SATISFACTION WITH A 6-MONTH INJECTION VERSUS A WEEKLY PILL FOR TREATMENT OF POSTMENOPAUSAL BONE LOSS." April 2009.

Silverman, S, Tosteson, A, Schousboe, J, Nichol, M, Gold, DT, and Borgstrom, F. "INTERNATIONAL COST AND UTILITIES RELATED TO OSTEOPOROSIS FRACTURE STUDY IN USA (ICUROS-US); STUDY DESIGN AND METHODS." April 2009.